The Potential Savings of E-Cigarettes for UK Healthcare

Aug.17.2023
The Potential Savings of E-Cigarettes for UK Healthcare
A new study from Brunel University London suggests encouraging smokers to switch to e-cigarettes could save the NHS up to £500 million annually.

A new study from Brunel University in London has found that encouraging smokers to switch to e-cigarettes could potentially save the UK's National Health Service (NHS) up to £500 million annually. The research team stated that despite the well-known harmful effects of tobacco smoking, it still poses a significant burden on NHS resources.


Despite widespread knowledge of the harmful effects of tobacco smoking, tobacco use remains the leading cause of preventable diseases and premature death in England. Current statistics reveal that:


In England, smoking is responsible for approximately 74,600 deaths annually in 2020. Additionally, smoking-related illnesses have led to approximately 506,100 admissions to NHS hospitals for treatment.


On the whole, experts suggest that this poses a burden of £2.5 billion annually on the UK's national healthcare system. The government has expressed determination in "significantly reducing this expenditure" while also maintaining its ambition of making England a "smoke-free" country by 2030.


A study conducted by Professor Francesco Moscone, an expert in business economics at Brunel University London, aimed to evaluate the potential savings to the NHS if some smokers in England switch to e-cigarettes. He stated, "Cancer, heart disease, stroke, chronic bronchitis, and emphysema are the five major disease categories caused by smoking. These diseases impose a significant burden on the NHS, and we are aware that the NHS is facing increasing pressure. Although the long-term effects of heat-not-burn tobacco systems are still unclear, we do know from previous research that alternative methods to traditional cigarettes can reduce exposure to key components of health risks by up to 90%.


In a study published in the British Journal of Medical Management, Professor Moscow Naideh calculated that switching to e-cigarettes would reduce smoking-related diseases by 70%. This is based on the assumption that they would no longer be exposed to the harmful chemicals found in traditional cigarettes.


Professor Francesco Moscone further added, "In a scenario where 50% of smokers switch to RRP, the NHS could save approximately £518 million per year. If the conversion rate is only 10%, the NHS would save £103 million. The adoption of RRP by smokers would significantly alleviate the pressure on the NHS, providing vital hospital resources for other treatments in need.


The study also highlights that this impact will have a geographical dimension, as the number of lung cancer patients in regions such as the Northeast and Yorkshire is almost twice as high as in other areas of England.


A professor has proven that smoking-related challenges in the Northeast and Yorkshire cost over £156 million every year. Therefore, encouraging smokers to switch to using e-cigarettes would offer the greatest benefits.


He concluded, "If 10% of smokers in the Northeast and Yorkshire region switch to RRP, the NHS would save a total of £30 million. If half of smokers in the region switch to RRP, the NHS would save £148 million. Embracing the transition to vapes not only has the potential to save millions for the NHS, but also presents a key opportunity to regain momentum and align with our ambitious 2030 plan. By embracing innovation and recognizing the potential of RRP, we can chart a future direction that firmly achieves our goals while reducing risks." It was reported last year that the government would "delay at least 7 years" to achieve the 2030 target unless urgent action is taken, and some social groups may not reach this target by 2044.


References:


Vaping has the potential to save the National Health Service (NHS) a staggering £500 million, a new report suggests. The study, conducted by researchers at the University of East Anglia, reveals that the NHS could save millions by promoting the use of e-cigarettes as a quit smoking aid. According to the research findings, if just 900,000 smokers switch from traditional cigarettes to vaping, the NHS could save an estimated £517 million in healthcare costs over a ten-year period. This could provide a significant financial boost for the struggling healthcare system. The study highlights the potential health benefits associated with vaping. While e-cigarettes are not entirely without risks, they have been proven to be far less harmful than conventional tobacco products. The report underscores that the use of e-cigarettes as an alternative can contribute to decreased smoking-related illnesses and subsequently alleviate the strain on the NHS. The savings are projected to come from reduced hospital visits and treatments for smoking-related diseases such as lung cancer, heart disease, and chronic obstructive pulmonary disease (COPD). The researchers argue that by encouraging smokers to switch to vaping, the NHS can prevent illnesses before they happen, leading to substantial cost savings in the long run. However, it is important to note that the report also urges caution when considering vaping as a solution to smoking. It states that while e-cigarettes have proven effective in helping smokers quit, they should not be viewed as a gateway to smoking among young people who have never smoked. Despite the concerns around youth vaping, the report's findings highlight the potential financial and health benefits that embracing vaping as a smoking cessation method can bring. By investing in resources to educate smokers on the benefits of e-cigarettes and providing adequate support in their transition, the NHS could save significant amounts of money while improving the nation's overall health.


This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.

PMI Faces Setback in India: Global Regulatory Fragmentation Complicates Its Smoke-Free Transition
PMI Faces Setback in India: Global Regulatory Fragmentation Complicates Its Smoke-Free Transition
India has reaffirmed its 2019 ban on e-cigarettes and heated tobacco devices, effectively blocking Philip Morris International (PMI) from launching IQOS in the country despite years of lobbying. Together with Taiwan, China’s conditional opening of heated tobacco products, and Japan’s planned 2026 excise tax hikes, these moves highlight increasingly divergent national regulatory pathways—an external uncertainty shaping PMI’s smoke-free growth trajectory.
Feb.12
Fontem Drops Texas Lawsuit and Plans to Refile in D.C. Over FDA Handling of Zone Application
Fontem Drops Texas Lawsuit and Plans to Refile in D.C. Over FDA Handling of Zone Application
Fontem US, the maker and seller of Zone nicotine pouches, has voluntarily dismissed its lawsuit against the U.S. Food and Drug Administration, which it had accused of unfairly delaying its market application.
Mar.25 by 2FIRSTS.ai
Research Summary | NHANES Study: Smoking or E-Cigarette Use Linked to Higher Prevalence of Elevated Blood Pressure and Hypertension
Research Summary | NHANES Study: Smoking or E-Cigarette Use Linked to Higher Prevalence of Elevated Blood Pressure and Hypertension
A cross-sectional analysis based on the US NHANES 2021–2023 cycle, including 6,262 participants aged over 12, found that compared with people who neither smoke nor vape, those who smoke and/or use e-cigarettes had a higher prevalence of elevated blood pressure and hypertension. After full adjustment, smoking/vaping was associated with elevated blood pressure (aOR 1.34) and hypertension (aOR 1.46), and with a 1.05 mmHg higher diastolic blood pressure.
Feb.09 by 2FIRSTS.ai
PMTA Roundtable Opens with Industry Questioning Product Characterization Standards, FDA Defends Regulatory Boundaries
PMTA Roundtable Opens with Industry Questioning Product Characterization Standards, FDA Defends Regulatory Boundaries
At the opening of FDA’s PMTA roundtable, small ENDS manufacturers warned that unclear product characterization standards are limiting their ability to invest and raise capital. FDA officials acknowledged industry concerns but said regulatory flexibility is constrained by statutory and procedural boundaries.
Feb.11
EVO NXT 2026 Offers Unique Insights Into A Dynamic Industry
EVO NXT 2026 Offers Unique Insights Into A Dynamic Industry
Feb.09
Global Forum on Nicotine 2026 to explore why prohibition of safer nicotine products risks, and does not protect, public health
Global Forum on Nicotine 2026 to explore why prohibition of safer nicotine products risks, and does not protect, public health
Mar.12